CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) ("CollPlant" or the "Company"), today announced that its Board of Directors has approved a one-for-ten reverse share split of the Company's ordinary shares. The reverse share split is scheduled to take effect when the Nasdaq Capital Market opens on September 4, 2026, at which point the Company's ordinary shares will begin trading on a split-adjusted basis under the existing ticker symbol "CLGN". The Board's decision follows shareholder approval grant